PSUSA/00000170/202401

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 19, Status: Authorised

Patient engagement in oncology

Human medicines European public assessment report (EPAR): Oxervate, cenegermin, Date of authorisation: 06/07/2017, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 14, Status: Authorised

Small and medium-sized enterprises info day, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 October 2024, 09:30 (CEST) to 18 October 2024, 16:15 (CEST)

Fostering regulatory collaboration to improve access to mpox medicines

Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 45, Status: Authorised

Highlights from the first Expert Panels and Notified Bodies workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024

Workshop with Notified Bodies on the Mandatory Scope of the CECP and PECP, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024